Cargando…
The MCL-1 BH3 Helix is an Exclusive MCL-1 inhibitor and Apoptosis Sensitizer
The development of selective inhibitors for discrete anti-apoptotic BCL-2 family proteins implicated in pathologic cell survival remains a formidable but pressing challenge. Precisely tailored compounds would serve as molecular probes and targeted therapies to study and treat human diseases driven b...
Autores principales: | Stewart, Michelle L., Fire, Emiko, Keating, Amy E., Walensky, Loren D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033224/ https://www.ncbi.nlm.nih.gov/pubmed/20562877 http://dx.doi.org/10.1038/nchembio.391 |
Ejemplares similares
-
A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation
por: Lee, Erinna F., et al.
Publicado: (2008) -
Designed BH3 Peptides with High Affinity and Specificity
for Targeting Mcl-1 in Cells
por: Foight, Glenna Wink, et al.
Publicado: (2014) -
Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors
por: Zhang, Shengzhe, et al.
Publicado: (2018) -
Photocatalytic proximity labelling of MCL-1 by a BH3 ligand
por: Beard, Hester A., et al.
Publicado: (2019) -
Allosteric Inhibition of Anti-Apoptotic MCL-1
por: Lee, Susan, et al.
Publicado: (2016)